Autophagy-preferential degradation of MIR224 participates in hepatocellular carcinoma tumorigenesis

Sheng Hui Lan, Shan Ying Wu, Roberto Zuchini, Xi Zhang Lin, Ih Jen Su, Ting Fen Tsai, Yen Ju Lin, Cheng Tao Wu, Hsiao Sheng Liu

研究成果: 雜誌貢獻文章同行評審

44 引文 斯高帕斯(Scopus)


Autophagy and microRNA (miRNA) are important regulators during cancer cell tumorigenesis. Impaired autophagy and high expression of the oncogenic microRNA MIR224 are prevalent in hepatocellular carcinoma (HCC); however, the relationship between the 2 phenomena remains elusive. In this study, we are the first to reveal that autophagy selectively regulates MIR224 expression through an autophagosome-mediated degradation system. Based on this finding, we further demonstrated that in hepatitis B virus (HBV)-related HCC, aberrant autophagy (low autophagic activity) results in accumulation of MIR224 and decreased expression of the target gene Smad4, which leads to increased cell migration and tumor formation. Preferential recruitment of MIR224 into the autophagosome was clearly demonstrated by a) miRNA in situ hybridization under confocal microscopy, and b) immunogold labeling of MIR224 under electron microscopy compared with a ubiquitously expressed microRNA MIRlet7e/let-7. Furthermore, we found that off-label use of amiodarone, an antiarrhythmic agent, effectively suppressed HCC tumorigenesis through autophagy-mediated MIR224 degradation both in vitro and in vivo. In summary, we identified amiodarone as a new autophagy inducer, which may provide an alternative approach in HCC therapy through a novel tumor suppression mechanism.
頁(從 - 到)1687-1689
出版狀態已發佈 - 9月 1 2014

ASJC Scopus subject areas

  • 分子生物學
  • 細胞生物學


深入研究「Autophagy-preferential degradation of MIR224 participates in hepatocellular carcinoma tumorigenesis」主題。共同形成了獨特的指紋。